Pierre-Olivier Goineau
Chief Executive Officer
Pierre-Olivier Goineau is a co-founder and Chief Executive Officer of ERYTECH. Prior to co-founding the Company, Pierre-Olivier worked as a management consultant at KPMG in Lyon, France where he was responsible for the healthcare practice. Pierre-Olivier is Vice President of the France Biotech Board, the French biotechnology association. Pierre-Olivier holds an MBA in finance and a MA in pharmaceutical industry from Lyon IAE University, France.

 Yann Godfrin, PhD
Executive Vice President and Chief Scientific Officer
Yann Godfrin is a co-founder, EVP and Chief Scientific Officer of ERYTECH. Prior to co-founding the Company, Yann was the R&D Director or Project Director at BioAlliance Pharma, Hemosystem, and Hemoxymed Europe. Yann is a biomedical engineer and holds a PhD in biology form the University of Nantes, France.

 Dr David Liens,
Medical Advisor
David Liens is the Medical Advisor of ERYTECH. Prior to joining the Company in 2008, he was Head of Clinical Development at Eusa Pharma-OPI, and International Medical Adviser at Merck KgaA. David holds a MD from the University of Lyon, France.

 Raphaële Beaudet
Director hospitals affairs
Raphaële is the Director hospitals affairs of ERYTECH. Prior to joining the company in 2011, she was a Business unit director immunology, haemostasis and intensive care at LFB and former marketing director and product manager at GLAXO and ZAMBON. Raphaële holds a Masters Degree in Molecular and Genetic Biology and a DESS in Industrial Pharmacy from the University of Lyon, France.

Jérôme Bailly
Director Pharmaceutical Operations, Qualified person
Jérôme is the Director of Pharmaceutical Operations and Qualified person of ERYTECH. Prior to joining the company in 2007, he was a production manager at Aguettant Laboratories and Skyepharma. Jérôme holds a PharmD from the University of Lyon, France and a Chemical Engineer, Polytechnique School of Montreal, Canada.